| PRODUCT NAME | HOLDER | STATUS | DATE | INDICATION |
|---|---|---|---|---|
| Hycamtin | Sandoz Pharmaceuticals d.d. | Authorised | 12/11/1996 | Ovarian Neoplasms;Uterine Cervical Neoplasms;Small Cell Lung Carcinoma |
| Topotecan Hospira | Pfizer Europe MA EEIG | Authorised | 09/06/2010 | Uterine Cervical Neoplasms;Small Cell Lung Carcinoma |
| Potactasol | Actavis Group PTC ehf | Authorised | 06/01/2011 | Uterine Cervical Neoplasms;Small Cell Lung Carcinoma |
| Topotecan Actavis | Actavis Group PTC ehf | Withdrawn | 24/07/2009 | Uterine Cervical Neoplasms;Small Cell Lung Carcinoma |
| Topotecan Teva | Teva B.V. | Withdrawn | 21/09/2009 | Ovarian Neoplasms;Uterine Cervical Neoplasms;Small Cell Lung Carcinoma |
| Topotecan Eagle | Eagle Laboratories Ltd. | Withdrawn | 22/12/2011 | Carcinoma;Small Cell Lung Carcinoma |
| Topotecan SUN | Sun Pharmaceutical Industries Europe B.V. | Application withdrawn | — | |
| Evotopin | Beecham Group plc | Withdrawn | 15/04/1997 | Ovarian Neoplasms |